Riluzole, a neuroprotective agent, preserves erectile function following bilateral cavernous nerve injury in male rats

Bratu O, Oprea I, Marcu D, Spinu D, Niculae A, Geavlete B, et al. Erectile dysfunction post-radical prostatectomy—a challenge for both patient and physician. J Med Life. 2017;10:13–8.

CAS  PubMed  PubMed Central  Google Scholar 

Burnett AL, Aus G, Canby-Hagino ED, Cookson MS, D’Amico AV, Dmochowski RR, et al. Erectile function outcome reporting after clinically localized prostate cancer treatment. J Urol. 2007;178:597–601.

Article  PubMed  Google Scholar 

Milenkovic U, Campbell J, Roussel E, Albersen M. An update on emerging drugs for the treatment of erectile dysfunction. Expert Opin Emerg Drugs. 2018;23:319–30.

Article  CAS  PubMed  Google Scholar 

Albersen M, Kendirci M, Van der Aa F, Hellstrom WJ, Lue TF, Spees JL. Multipotent stromal cell therapy for cavernous nerve injury-induced erectile dysfunction. J Sex Med. 2012;9:385–403.

Article  CAS  PubMed  Google Scholar 

Bannowsky A, Schulze H, van der Horst C, Hautmann S, Jünemann KP. Recovery of erectile function after nerve-sparing radical prostatectomy: improvement with nightly low-dose sildenafil. BJU Int. 2008;101:1279–83.

Article  CAS  PubMed  Google Scholar 

Ryu JK, Suh JK, Burnett AL. Research in pharmacotherapy for erectile dysfunction. Transl Androl Urol. 2017;6:207–15.

Article  Google Scholar 

Campbell JD, Burnett AL. Neuroprotective and nerve regenerative approaches for treatment of erectile dysfunction after cavernous nerve injury. Int J Mol Sci. 2017;18:1794.

Article  PubMed  PubMed Central  Google Scholar 

Mizoule J, Meldrum B, Mazadier M, Croucher M, Ollat C, Uzan A, et al. 2-Amino-6-trifluoromethoxy benzothiazole, a possible antagonist of excitatory amino acid neurotransmission—I. Anticonvulsant properties. Neuropharmacology. 1985;24:767–73.

Article  CAS  PubMed  Google Scholar 

Gourley SL, Espitia JW, Sanacora G, Taylor JR. Antidepressant-like properties of oral riluzole and utility of incentive disengagement models of depression in mice. Psychopharmacology (Berl). 2012;219:805–14.

Article  CAS  PubMed  Google Scholar 

Sugiyama A, Saitoh A, Iwai T, Takahashi K, Yamada M, Sasaki-Hamada S, et al. Riluzole produces distinct anxiolytic-like effects in rats without the adverse effects associated with benzodiazepines. Neuropharmacology. 2012;62:2489–98.

Article  CAS  PubMed  Google Scholar 

Bausch AR, Roy G. Volume-sensitive chloride channels blocked by neuroprotective drugs in human glial cells (U-138MG). Glia. 1996;18:73–7.

Article  CAS  PubMed  Google Scholar 

Huang CS, Song JH, Nagata K, Yeh JZ, Narahashi T. Effects of the neuroprotective agent riluzole on the high voltage-activated calcium channels of rat dorsal root ganglion neurons. J Pharmacol. Exp Ther. 1997;282:1280–90.

CAS  PubMed  Google Scholar 

Zarate CA, Manji HK. Riluzole in psychiatry: a systematic review of the literature. Expert Opin Drug Metab Toxicol. 2008;4:1223–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fumagalli E, Funicello M, Rauen T, Gobbi M, Mennini T. Riluzole enhances the activity of glutamate transporters GLAST, GLT1 and EAAC1. Eur J Pharmacol. 2008;578:171–6.

Article  CAS  PubMed  Google Scholar 

Yoo MH, Hyun H-J, Koh J-Y, Yoon YH. Riluzole inhibits VEGF-induced endothelial cell proliferation in vitro and hyperoxia-induced abnormal vessel formation in vivo. Invest Ophthalmol Vis Sci. 2005;46:4780–7.

Article  PubMed  Google Scholar 

Noh KM, Hwang JY, Shin HC, Koh JY. A novel neuroprotective mechanism of riluzole: direct inhibition of protein kinase C. Neurobiol Dis. 2000;7:375–83.

Article  CAS  PubMed  Google Scholar 

Miletic V, Bowen KK, Miletic G. Loose ligation of the rat sciatic nerve is accompanied by changes in the subcellular content of protein kinase C beta II and gamma in the spinal dorsal horn. Neurosci Lett. 2000;288:199–202.

Article  CAS  PubMed  Google Scholar 

Ganel R, Crosson CE. Modulation of human glutamate transporter activity by phorbol ester. J Neurochem. 1998;70:993–1000.

Article  CAS  PubMed  Google Scholar 

Casado M, Zafra F, Aragón C, Giménez C. Activation of high-affinity uptake of glutamate by phorbol esters in primary glial cell cultures. J Neurochem. 1991;57:1185–90.

Article  CAS  PubMed  Google Scholar 

Kalandadze A, Wu Y, Robinson MB. Protein kinase C activation decreases cell surface expression of the GLT-1 subtype of glutamate transporter. Requirement of a carboxyl-terminal domain and partial dependence on serine 486. J Biol Chem. 2002;277:45741–50.

Article  CAS  PubMed  Google Scholar 

González MI, Robinson MB. Protein kinase C-dependent remodeling of glutamate transporter function. Mol Interv. 2004;4:48–58.

Article  PubMed  Google Scholar 

Wu Y, Satkunendrarajah K, Teng Y, Chow DSL, Buttigieg J, Fehlings MG. Delayed post-injury administration of riluzole is neuroprotective in a preclinical rodent model of cervical spinal cord injury. J Neurotrauma. 2013;30:441–52.

Article  PubMed  PubMed Central  Google Scholar 

Coderre TJ, Kumar N, Lefebvre CD, Yu JSC. A comparison of the glutamate release inhibition and anti-allodynic effects of gabapentin, lamotrigine, and riluzole in a model of neuropathic pain. J Neurochem. 2007;100:1289–99.

Article  CAS  PubMed  Google Scholar 

Canguven O, Burnett A. Cavernous nerve injury using rodent animal models. J Sex Med. 2008;5:1776–85.

Article  PubMed  Google Scholar 

Sezen SF, Hoke A, Burnett AL, Snyder SH. Immunophilin ligand FK506 is neuroprotective for penile innervation. Nat Med. 2001;7:1073–4.

Article  CAS  PubMed  Google Scholar 

Chew DJ, Carlstedt T, Shortland PJ. The effects of minocycline or riluzole treatment on spinal root avulsion-induced pain in adult rats. J Pain. 2014;15:664–75.

Article  CAS  PubMed  Google Scholar 

Canguven O, Lagoda G, Sezen SF, Burnett AL. Losartan preserves erectile function after bilateral cavernous nerve injury via antifibrotic mechanisms in male rats. J Urol. 2009;181:2816–22.

Article  CAS  PubMed  Google Scholar 

Musicki B, Bhunia AK, Karakus S, Burnett AL. S-nitrosylation of NOS pathway mediators in the penis contributes to cavernous nerve injury-induced erectile dysfunction. Int J Impot Res. 2018;30:108–16.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Medico M, Nicosia A, Grech M, Onesta M, Sessa G, Rampello L, et al. Riluzole restores motor activity in rats with post-traumatic peripheral neuropathy. Neurosci Lett. 2004;358:37–40.

Article  CAS  PubMed  Google Scholar 

Carbone M, Duty S, Rattray M. Riluzole neuroprotection in a Parkinson’s disease model involves suppression of reactive astrocytosis but not GLT-1 regulation. BMC Neurosci. 2012;13:38.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yilmaz-Oral D, Onder A, Kaya-Sezginer E, Oztekin CV, Zor M, Gur S. Restorative effects of red onion (Allium cepa L.) juice on erectile function after-treatment with 5α-reductase inhibitor in rats. Int J Impot Res. 2022;34:269–76.

Article  CAS  PubMed  Google Scholar 

Sezen SF, Burnett AL. Intracavernosal pressure monitoring in mice: responses to electrical stimulation of the cavernous nerve and to intracavernosal drug administration. J Androl. 2000;21:311–5.

CAS  PubMed  Google Scholar 

Hannan JL, Kutlu O, Stopak BL, Liu X, Castiglione F, Hedlund P, et al. Valproic acid prevents penile fibrosis and erectile dysfunction in cavernous nerve-injured rats. J Sex Med. 2014;11:1442–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Engin S, Yasar YK, Barut EN, Sezen SF. Improved endothelium-dependent relaxation of thoracic aorta in niclosamide-treated diabetic rats. Cardiovasc Toxicol. 2021;21:563–71.

Article  CAS  PubMed  Google Scholar 

Abraham-Juárez, MJ. Western blot in maize. Bio-protoc. 2019;101:e3257.

Capogrosso P, Salonia A, Briganti A, Montorsi F. Postprostatectomy erectile dysfunction: a review. World J Mens Health. 2016;34:73–88.

Article  PubMed  PubMed Central  Google Scholar 

Burnett AL. Strategies to promote recovery of cavernous nerve function after radical prostatectomy. World J Urol. 2003;20:337–42.

Article  PubMed  Google Scholar 

Emanu JC, Avildsen IK, Nelson CJ. Erectile dysfunction after radical prostatectomy: Prevalence, medical treatments, and psychosocial interventions. Curr Opin Support Palliat Care. 2016;10:102–7.

Article 

留言 (0)

沒有登入
gif